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Malaria is one of the most important parasitic dis-
eases in the world, causing significant mortality and mor-
bidity in the tropical regions1. Although symptoms can 
range from a mild fever to severe complicated forms, 
there are limited published data on cardiac involve-
ment of malaria and only a few studies have been car-
ried out regarding cardiac function in severe malaria2–3. 
Cardiac involvement in the course of malaria ranges 
from severe forms with hypatension, shock, circula-
tory collapse and impaired haemodynamic function, 
to mild disorders documented by Electrocardiogram 
(ECG) and echocardiography4–6. Pericardial involve-
ment in malaria is a very rare event7–8. We report here two 
cases of falciparum malaria complicated with pericardial 
effusion.
Case 1: A 19-yr-old Nigerian female, resident of 
Sicily, was admitted with history of intermittent high-
grade fever over three days, following her return from 
Nigeria, 10 days prior to the onset of the symptoms. The 
fever was associated with headaches as well as thoracic 
pain during the episodes. The patient denied neck stiff-
ness. There was no history of diabetes, hypertension or 
dyslipidaemia. On examination the patient was apyretic, 
eupneic, blood pressure was 120/70 mmHg with a pulse 
rate of 105 bpm. Neck stiffness and peripheral oedema 
were absent and there was no active bleeding from any 
site. Neurological examination was normal. Hepatomeg-
aly was absent and the spleen was palpable with a long 
axis of approximately 13 cm. Cardiovascular examina-
tion identified a systolic murmur and pericardial rub. 
White blood cells (WBCs) count was 6600/mm3, platelet 
count was 54000/mm3 indicating thrombocytopenia, hae-
moglobin was 8.2 g/dl, and blood glucose was 110 mg/dl; 
coagulation profile revealed an INR of 1.38, a D-dimer 
of 949 ng/dl and a fibrinogen of 502 mg/dl. Liver func-
tion tests displayed a GGT of 56 IU/L and LDH of 232 
IU/L. Renal function tests showed a blood urea of 21 mg/
dl and a serum creatinine of 0.8 mg/dl. C-reactive protein 
levels were elevated at 14.95 mg/l. Blood smear was posi-
tive for Plasmodium falciparum with 1.5% parasitaemia. 
Virological screen was negative for human immunodefi-
ciency virus (HIV) and cytomegalovirus  (CMV).
ECG showed sinus tachycardia of 106 bpm and dif-
fuse non-specific abnormality of  ST-T wave. The echo-
cardiogram, performed to investigate the cause of the 
thoracic pain, revealed an anterior non-compressive peri-
cardial effusion (6 mm behind the right atrium, 9 mm in 
lateral) and a congenital intra-atrial and intra-ventricular 
communication with left-to-right shunt. Chest X-ray was 
normal.
The patient was treated with a co-formulation of di-
hydroartemisinin (DHA)-piperaquine (PPQ) 120 mg/960 
mg orally (po) once daily for three days. The patient also 
started treatment for pericarditis under the supervision of 
a cardiologist with colchicine 1 mg po daily and ibuprofen 
600 mg every 8 h (as attack dose for a week, then every 12 
h for another week). 
There was a favourable evolution throughout seven 
days of admission, with an improvement of symptomatol-
ogy. Repeat blood smear at the end of antimalaria therapy 
showed no evidence of malarial parasites. Patient was 
discharged after 16 days in good and stable clinical con-
dition, with colchicine therapy for a total period of three 
months. An appropriate follow-up plan was agreed upon 
as recommended.
Case 2:A 52-yr-old Ghanese woman, residing in Sic-
ily, was admitted with history of abdominal pain and fe-
ver over five days, following her return from Ghana, 15 
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days prior to the onset of the symptoms. On admission, 
she appeared suffering, but without altered state of con-
sciousness. On examination the patient was febrile (body 
temperature 39 °C), eupneic, with blood pressure 120/60 
mmHg. There were no signs of meningeal irritation, cog-
nitive impairment or any neurological deficit. She had no 
hepatosplenomegaly. A cardiac examination revealed soft 
heart sounds, with pericardial friction rub.
Laboratory studies showed a WBC count of 24200/
mm3 (neutrophils 89.7%, lymphocytes 5.5%); haemoglo-
bin level 8.6 g/l, platelets count 17000/mm3, C-Reactive 
protein 198 mg/l, D-dimer 15.112 mg/l. Examination of a 
thin blood smear revealed ring trophozoites typical of P. 
falciparum including multiple infected cells with 3.7% 
of erythrocytes parasitized. Quanti FERON-TB-Gold test 
and viral serology for HIV were negative.
ECG showed sinus tachycardia of 110 bpm. Trans-
thoracic echocardiography (TE) showed a left ventricu-
lar concentric hypertrophy with preserved global sys-
tolic function, absence of any segmental wall-motion 
abnormalities of the left ventricle; right sections were 
of normal size with preserved right ventricular func-
tion. It also showed pericardial effusion (8 mm be-
hind the right atrium, 12 mm in lateral) without hae-
modynamic consequences (Fig. 1). The patient was 
treated for malaria infection with a co-formulation of 
dihydroartemisinin (DHA)-piperaquine (PPQ) 120 
mg/960 mg po once daily for three days. In agreement 
with 2015 ESC guidelines9 the patient was treated for 
pericarditis with ibuprofen 600 mg po every 8 h (as at-
tack dose for a week, then every 12 h for another week) 
plus colchicine 1 mg po daily. Over four days after initia-
tion of antimalaria therapy, the patient’s clinical condi-
tion improved. Repeat blood smear at the end of antima-
laria therapy showed no evidence of malarial parasites. 
On Day 12 of hospitalization, a control TE confirmed 
the presence of a minor pericardial effusion (4 mm in 
lateral), with no signs of haemodynamic compromise. 
The patient was discharged on the 14th day in good 
condition, with colchicine therapy for a total period of 
three months.
DISCUSSION
Falciparum malaria has a wide range of symptoms, 
and can be complicated by acute renal insufficiency, ce-
rebral malaria, acidosis and acute respiratory distress 
syndrome4. Cardiac involvement is rarely seen and, when 
present, affects predominantly the myocardium and the 
myoelectric system5, 10. Features of myocarditis, ectopic 
ECG changes, conduction defects, tachy-brady-arrhyth-
mias and acute heart failure with reduced cardiac output 
have been observed in a few cases of imported severe 
falciparum malaria10-14. In the present cases, both the pa-
tients developed pericardial effusion. Whilst myocardial 
damage appears to retain a multifactorial pathogenesis, 
being probably the result of mechanical (microcirculato-
ry obstruction), metabolic (systemic acidosis and related 
tissue hypo-oxygenation), and humoral mechanisms; the 
mechanism underlying the causal relationship between 
the parasitic infection and the development of pericardial 
effusion is still unclear. One possible explanation may 
be the locally elevated cytokine levels. Day et al15 have 
shown that cytokines produced locally in particular tissue 
during malarial infection may be regulated by the degree 
of regional parasitic sequestration; and the documenta-
tion of parasitic antigen, by Kohli et al8, in the pericardial 
fluid has also confirmed the association of malaria and 
pericardial effusion.
Plasmodium falciparum has the unique capability of 
causing cytoadherence, where parasitised RBCs become 
sequestered in capillaries. It has been shown that the pro-
duction of pro-inflammatory cytokines can be regulated 
by the extent of cytoadherence in specific areas16. The 
pro-inflammatory state created locally alters the dynamic 
equilibrium between the pericardial fluid and the blood 
serum. Local production of inflammatory mediators can 
bring about the extravasation of fluid from the visceral 
pericardium into the virtual space between the two layers. 
In addition, the exudation of large molecules increases the 
osmotic potential inside the pericardial sheets and per-
petuates the vicious cycle installed.
In the light of earlier reports, it is reasonable to con-
clude that pericardial effusion must be deemed a serious 
complication of falciparum malaria. This is crucial insight 
to prevent cardiac tamponade, a potentially fatal compli-







Fig. 1: Echocardiography showing a circumcardiac pericardial effu-
sion (yellow arrow) in parasternal long axis (left) and apical 
4 chamber (right).
 J Vector Borne Dis 54, December 2017374 
Conflict of interest
There are not any affiliation, financial agreement, 
or other involvement of any author with the companies 
whose products figure prominently in the submitted type-
script.
Ethical statement
Written informed consent was obtained from the 
patients for publication of this case report and any 
accompanying images. A copy of the written consent is 
available for review by the Editor/Editor-in-Chief of this 
journal.
REFERENCES
1. World Malaria Report 2015. Geneva: World Health Organiza-
tion 2015; p. 280.
2. Ehrhardt S, Mockenhaupt FP, Anemana SD, Otchwemah RN, 
Wichmann D, Cramer JP, et al. High levels of circulating cardi-
ac proteins indicate cardiac impairment in African children with 
severe Plasmodium falciparum malaria. Microbes Infect 2005; 
7(11–12): 1204–10. 
3. Yacoub S, Lang HJ, Shebbe M, Timbwa M, Ohuma E, Tulloh 
R, et al. Cardiac function and hemodynamics in Kenyan 
children with severe malaria. Crit Care Med 2010; 38(3): 
940–5. 
4. Severe falciparum malaria. World Health Organization, Com-
municable Diseases Cluster. Trans R Soc Trop Med Hyg 2000; 
94 (Suppl 1): S1–90. 
5. Mishra SK, Behera PK, Satpathi S. Cardiac involvement in ma-
laria: An overlooked important complication. J Vector Borne 
Dis 2013; 50(3): 232–5.
6. Hooda AK, Varma PP, Dutta V. Fatal cardiac tamponade in ma-
larial acute renal failure. Ren Fail 2007; 29(3): 371–3.
7. Franzen D, Curtius JM, Heitz W, Höpp HW, Diehl V, Hilger 
HH. Cardiac involvement during and after malaria. Clin Inves-
tig 1992; 70(8): 670–3.
8. Kohli R, Gulati S, Kapoor A, Singh S. Cardiac tamponade: 
An unusual complication of Plasmodium falciparum-induced 
acute renal failure. Nephrol Dial Transplant 2003; 18(8): 
1678–9.
9. Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, 
Bogaert J, et al. ESC guidelines for the diagnosis and manage-
ment of pericardial diseases: The task force for the diagnosis 
and management of pericardial diseases of the European Soci-
ety of Cardiology (ESC) Endorsed by: The European Associa-
tion for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015; 
36(42): 2921–64.
10. Costenaro P, Benedetti P, Facchin C, Mengoli C, Pellizzer G. 
Fatal myocarditis in course of Plasmodium falciparum infec-
tion: Case report and review of cardiac complications in ma-
laria. Case Rep Med 2011; 2011: 202083.
11. Wichmann O, Löscher T, Jelinek T. Fatal malaria in a German 
couple returning from Burkina Faso. Infection 2003; 31(4): 
260–2.
12. Kumar D, Kapoor A. Cardiac involvement in falciparum ma-
laria: A brief report. Clin Pediatr (Phila) 2013; 52(4): 362–3.
13. Mohsen AH, Green ST, West JN, McKendrick MW. Myocar-
ditis associated with Plasmodium falciparum malaria: A case 
report and a review of the literature. J Travel Med 2001; 8(4): 
219–20.
14. Bhat S, Alva J, Muralidhara K, Fahad S. Malaria and the heart. 
BMJ Case Rep 2012; 27; 2012 
15. Day NP, Hien TT, Schollaardt T, Loc PP, Chuong LV, Chau TT 
et al. The prognostic and pathophysiologic role of pro- and anti-
inflammatory cytokines in severe malaria. J Infect Dis 1999; 
180(4): 1288–97.
16. Craig AG, Khairul MF, Patil PR. Cytoadherence and severe ma-
laria. Malays J Med Sci 2012; 19(2): 5–18.
Correspondence to: Dr Claudia Colomba, Department of Sciences for Health Promotion and Mother and Child Care, Section of Infectious 
Diseases, University of Palermo, Italy.
 E-mail: claudia.colomba@libero.it
Received: 7 December 2016                        Accepted in revised form: 11 July 2017
Copyright of Journal of Vector Borne Diseases is the property of National Institute of Malaria
Research (ICMR) and its content may not be copied or emailed to multiple sites or posted to a
listserv without the copyright holder's express written permission. However, users may print,
download, or email articles for individual use.
